«MS State of the Art Symposium»

C. Lotter zum «MS State of the Art Symposium», dem Stellenwert der Forschung und den Aufgaben der Schweiz. MS-Gesellschaft | Christoph Lotter, Co-Direktor Schweiz. MS-Gesellschaft

M. Puhan, Referent am MS State of the Art 2021, über seine Motivation und Forschungstätigkeit | Milo Puhan, University of Zurich, Epidemiology, Biostatistics and Prevention Institute

Christoph Lotter underlines the importance of research and thanks all participants and researchers for their fight against MS | Christoph Lotter, Co-Director Swiss MS Society

The Corona Pandemic and MS - First Line Clinical, Epidemiological and Health Policy Insights | Jan Fehr, University Hospital Zurich, Department of Infectious Diseases and Hospital Epidemiology & Milo Puhan, University of Zurich, Epidemiology, Biostatistics and Prevention Institute | chaired by Adam Czaplinski, Bellevue Medical Group, Neurology FMH

Poster Blitz – MS Society Research Projects at a Glance | Introduction by Britta Engelhardt, University of Bern, Theodor Kocher Institute. The Swiss MS Society supports research projects in the field of Multiple Sclerosis with considerable financial contributions. The «Poster Blitz» gives a brief overview of a selection of current research projects.

Swiss Covid-19 Data in the European LEOSS Registry | Robert Hoepner, University Hospital Bern, Department of Neurology | chaired by Caroline Pot, Lausanne University Hospital, Neurology Clinic

The French COVISEP Registry | Céline Louapre, Pitié Salpêtrière Hospital, Paris (FR), Department of Neurology & Sorbonne Université, Paris (FR), Institut du Cerveau | chaired by Caroline Pot, Lausanne University Hospital, Neurology Clinic

MS and Vaccinations | Matthias Mehling, University Hospital Basel, Neurology Clinic and Policlinic | Research Center for Clinical Neuroimmunology and Neuroscience | chaired by Gabrielle Di Virgilio, Centre Hospitalier de Rennaz, Neurology Unit

Risk of PML in Multiple Sclerosis Therapies | Renaud Du Pasquier, Lausanne University Hospital (CHUV), Service of Neurology | chaired by Ilijas Jelcic, University Hospital Zurich, Neurology Clinic

Treatment Landscape of MS and NMOSD 2021| Andrew Chan, University Hospital Bern, Department of Neurology, Medical Division Neuro | chaired by Stefanie Müller, Cantonal Hospital of St. Gallen, Neurology Clinic

Treatment Landscape of MS and NMOSD 2021 | Anke Salmen, University Hospital Bern, Department of Neurology | chaired by Stefanie Müller, Cantonal Hospital of St. Gallen, Neurology Clinic